Author

M. Nallani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

J. H. Lam· 2 shared T. W. Chia· 2 shared A. K. Khan· 1 shared D. E. Anderson· 1 shared D. Shivhare· 1 shared F. Ginhoux· 1 shared F. W. I. Lim· 1 shared G. Sinsinbar· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. H. Lam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of concern and early reduction in viral load of the upper airway in the golden Syrian hamster model

J. H. Lam, D. Shivhare, T. W. Chia, S. L. Chew, G. Sinsinbar, T. Y. Aw, S. Wong, S. Venkataraman, F. W. I. Lim, P. Vandepapeliere, M. Nallani

This paper develops an intranasal polymersome-based vaccine that provides robust protection against multiple SARS-CoV-2 variants and reduces viral load in hamsters.

bioRxiv · Feb 12, 2022 · PreprintImmunology

Next generation vaccine platform: polymersomes as stable nanocarriers for a highly immunogenic and durable SARS-CoV-2 spike protein subunit vaccine

J. H. Lam, A. K. Khan, T. A. Cornell, R. J. Dress, T. W. Chia, W. W. W. Yeow, N. K. Mohd-Ismail, S. Venkatraman, K. T. Ng, Y.-J. Tan, D. E. Anderson, F. Ginhoux, M. Nallani

This paper develops a subunit vaccine using polymersomes to deliver SARS-CoV-2 spike protein and CpG adjuvant, showing robust and durable immune responses in mice.

bioRxiv · Jan 24, 2021 · PreprintImmunology